62 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
of an industry group that supports the NEuroCOUGH consortium, within the European Respiratory Society. The NEuroCOUGH consortium hosts a platform
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
stock company), firm, society, or other enterprise, association, organization, or entity.
“ERISA” means the U.S. Employee Retirement Income Security
6-K
EX-99.2
BLU
Bellus Health Inc
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
to be consistent with previous camlipixant trials and no taste-related adverse events reported.
Presenting at the upcoming American Thoracic Society … Academy of Allergy, Asthma & Immunology (“AAAAI”) Annual Meeting and at the American Society of Clinical Pharmacology & Therapeutics (“ASCPT”) 2023
6-K
EX-99.1
BLU
Bellus Health Inc
12 May 23
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
4:02pm
, Quebec, Canada H7V 4A7
Presenting at the upcoming American Thoracic Society (“ATS”) 2023 International Conference, being held in Washington, DC from May … & Immunology (“AAAAI”) Annual Meeting and at the American Society of Clinical Pharmacology & Therapeutics (“ASCPT”) 2023 Annual Meeting.
The Company
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
, estate, trust, company (including any company limited by shares, limited liability company, or joint stock company), firm, society, or other enterprise
6-K
EX-99.2
gka9flfnk8bp
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
zhe66lx4g8m2gv4u3
29 Mar 23
Current report (foreign)
5:26pm
6-K
EX-99.2
rg267o d4m99nfpvwf
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
SUPPL
86iu2hy5bi
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
kbkd6 nyf
14 Nov 22
BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights
4:03pm
F-10
oxrcssf6l
26 Aug 22
Registration of securities (Canada)
4:48pm
6-K
EX-99.1
sn2qhn0
22 Aug 22
Bellus Health Inc. 6-K
7:01am
6-K
yttwhm
22 Aug 22
Bellus Health Inc. 6-K
7:01am
6-K
EX-99.2
6gnvhlqv378
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
6-K
EX-99.1
3vrv1
10 Aug 22
BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights
4:31pm
SUPPL
pb7ka6g vzoofnkq
15 Jul 22
Supplemental materials (foreign)
7:01am
SUPPL
d4srwczqr y96tm97l
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.1
9s8z541r6tmkkss
11 May 22
BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights
5:23pm
6-K
EX-99.2
6tf3q46yul6m6p69yy3b
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.1
kosc9f6hdq6
2 May 22
BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference
7:00am